Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial

Purpose To investigate the impact of hydrocortisone treatment and illness severity on health-related quality of life (HRQoL) at 6 months in septic shock survivors from the ADRENAL trial. Methods Using the EuroQol questionnaire (EQ-5D-5L) at 6 months after randomization we assessed HRQoL in patient s...

Full description

Saved in:
Bibliographic Details
Published in:Intensive care medicine 2020-09, Vol.46 (9), p.1696-1706
Main Authors: Hammond, Naomi E., Finfer, Simon R., Li, Qiang, Taylor, Colman, Cohen, Jeremy, Arabi, Yaseen, Bellomo, Rinaldo, Billot, Laurent, Harward, Meg, Joyce, Christopher, McArthur, Colin, Myburgh, John, Perner, Anders, Rajbhandari, Dorrilyn, Rhodes, Andrew, Thompson, Kelly, Webb, Steve, Venkatesh, Balasubramanian
Format: Article
Language:eng
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To investigate the impact of hydrocortisone treatment and illness severity on health-related quality of life (HRQoL) at 6 months in septic shock survivors from the ADRENAL trial. Methods Using the EuroQol questionnaire (EQ-5D-5L) at 6 months after randomization we assessed HRQoL in patient subgroups defined by hydrocortisone or placebo treatment, gender, illness severity (APACHE II 
ISSN:0342-4642
1432-1238